OVERSEA CHINESE BANKING Corp Ltd Sells 80,762 Shares of Colgate-Palmolive (NYSE:CL)

OVERSEA CHINESE BANKING Corp Ltd decreased its holdings in Colgate-Palmolive (NYSE:CL) by 62.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,478 shares of the company’s stock after selling 80,762 shares during the period. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Colgate-Palmolive were worth $4,499,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $26,000. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $32,000. Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $32,000. Finally, Wintrust Investments LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $33,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL opened at $89.45 on Wednesday. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market capitalization of $72.59 billion, a P/E ratio of 25.41, a P/E/G ratio of 4.20 and a beta of 0.40. The business’s 50-day moving average is $89.13 and its two-hundred day moving average is $94.44.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 EPS. Research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday, March 14th. Morgan Stanley decreased their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $101.72.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.